Shalaby Mohammad A, Alhasan Khalid A, Sandokji Ibrahim A, Albanna Amr S, Almukhtar Zahrah, Elhaj Hind Khalifa, Alwadai Khaled, Bahassan Abdulaziz, Temsah Mohamad-Hani, Raina Rupesh, Kari Jameela A
Pediatric Department, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Pediatric Nephrology Unit, Pediatric Nephrology Center of Excellence, King Abdulaziz University Hospital, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
J Clin Med. 2024 Nov 8;13(22):6720. doi: 10.3390/jcm13226720.
Acute kidney injury (AKI) is a major concern in pediatric critical care, often occurring in conjunction with sepsis. This study aimed to identify the incidence, outcomes, and risk factors for AKI in the context of pediatric sepsis. This was a bicentric retrospective cohort study conducted at two university hospitals in Saudi Arabia. All patients aged 1 month to 14 years admitted to pediatric intensive care units (PICUs) with evidence of sepsis between January 2021 and December 2022 were included. AKI was defined and staged according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Demographic, clinical, and laboratory data were collected from electronic medical records. 309 patients were included, 38 (12.3%) developed stage 1 AKI, 64 (20.7%) developed stage 2 AKI, and 183 (59.2%) developed stage 3 AKI. Patients with sepsis-associated AKI had significantly longer PICU stays and higher mortality rates than those without AKI ( < 0.01). Inflammatory markers and certain medications were associated with increased AKI risk. Factors independently associated with stage 3 AKI include younger age, positive blood culture, gentamycin use, and higher SOFA score. Sepsis-associated AKI is a common and serious complication in critically ill children, contributing to increased morbidity and mortality. Identification of specific risk factors may facilitate early recognition and targeted interventions to mitigate the impact of AKI in this vulnerable population.
急性肾损伤(AKI)是儿科重症监护中的一个主要问题,常与脓毒症同时发生。本研究旨在确定儿科脓毒症背景下AKI的发病率、结局及危险因素。这是一项在沙特阿拉伯两家大学医院进行的双中心回顾性队列研究。纳入2021年1月至2022年12月期间入住儿科重症监护病房(PICUs)且有脓毒症证据的所有1个月至14岁的患者。AKI根据改善全球肾脏病预后组织(KDIGO)标准进行定义和分期。从电子病历中收集人口统计学、临床和实验室数据。共纳入309例患者,38例(12.3%)发生1期AKI,64例(20.7%)发生2期AKI,183例(59.2%)发生3期AKI。脓毒症相关AKI患者的PICU住院时间明显长于无AKI患者,死亡率也更高(<0.01)。炎症标志物和某些药物与AKI风险增加有关。与3期AKI独立相关的因素包括年龄较小、血培养阳性、使用庆大霉素和较高的序贯器官衰竭评估(SOFA)评分。脓毒症相关AKI是危重症儿童常见且严重的并发症,会导致发病率和死亡率增加。识别特定危险因素可能有助于早期识别并采取针对性干预措施,以减轻AKI对这一脆弱人群的影响。